90 related articles for article (PubMed ID: 7675455)
1. Step-wise progression in human skin carcinogenesis in vitro involves mutational inactivation of p53, rasH oncogene activation and additional chromosome loss.
Boukamp P; Peter W; Pascheberg U; Altmeier S; Fasching C; Stanbridge EJ; Fusenig NE
Oncogene; 1995 Sep; 11(5):961-9. PubMed ID: 7675455
[TBL] [Abstract][Full Text] [Related]
2. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
Bowden GT; Schneider B; Domann R; Kulesz-Martin M
Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
[TBL] [Abstract][Full Text] [Related]
3. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.
Williams AC; Browne SJ; Yeudal WA; Paterson IC; Marshall CJ; Lane DP; Paraskeva C
Oncogene; 1993 Nov; 8(11):3063-72. PubMed ID: 8414507
[TBL] [Abstract][Full Text] [Related]
4. Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.
Negrini M; Sabbioni S; Haldar S; Possati L; Castagnoli A; Corallini A; Barbanti-Brodano G; Croce CM
Cancer Res; 1994 Apr; 54(7):1818-24. PubMed ID: 8137297
[TBL] [Abstract][Full Text] [Related]
5. Loss of retinoic acid receptors in mouse skin and skin tumors is associated with activation of the ras(Ha) oncogene and high risk for premalignant progression.
Darwiche N; Scita G; Jones C; Rutberg S; Greenwald E; Tennenbaum T; Collins SJ; De Luca LM; Yuspa SH
Cancer Res; 1996 Nov; 56(21):4942-9. PubMed ID: 8895748
[TBL] [Abstract][Full Text] [Related]
6. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
[TBL] [Abstract][Full Text] [Related]
7. Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis.
Weinberg WC; Montano NE; Deng C
Oncogene; 1997 Aug; 15(6):685-90. PubMed ID: 9264409
[TBL] [Abstract][Full Text] [Related]
8. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P
Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
10. p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene.
Weinberg WC; Azzoli CG; Kadiwar N; Yuspa SH
Cancer Res; 1994 Nov; 54(21):5584-92. PubMed ID: 7923201
[TBL] [Abstract][Full Text] [Related]
11. Genetic instability in the 9q22.3 region is a late event in the development of squamous cell carcinoma.
Ahmadian A; Ren ZP; Williams C; Pontén F; Odeberg J; Pontén J; Uhlén M; Lundeberg J
Oncogene; 1998 Oct; 17(14):1837-43. PubMed ID: 9778050
[TBL] [Abstract][Full Text] [Related]
12. Functional loss of tumour suppressor genes in multistage chemical carcinogenesis.
Balmain A; Kemp CJ; Burns PA; Stoler AB; Fowlis DJ; Akhurst RJ
Princess Takamatsu Symp; 1991; 22():97-108. PubMed ID: 1844254
[TBL] [Abstract][Full Text] [Related]
13. Ras mutation promotes p53 activation and apoptosis of skin keratinocytes.
Zhao Y; Chaiswing L; Bakthavatchalu V; Oberley TD; St Clair DK
Carcinogenesis; 2006 Aug; 27(8):1692-8. PubMed ID: 16613839
[TBL] [Abstract][Full Text] [Related]
14. P53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints.
Agapova LS; Ivanov AV; Sablina AA; Kopnin PB; Sokova OI; Chumakov PM; Kopnin BP
Oncogene; 1999 May; 18(20):3135-42. PubMed ID: 10340385
[TBL] [Abstract][Full Text] [Related]
15. Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes.
Ren ZP; Hedrum A; Pontén F; Nistér M; Ahmadian A; Lundeberg J; Uhlén M; Pontén J
Oncogene; 1996 Feb; 12(4):765-73. PubMed ID: 8632898
[TBL] [Abstract][Full Text] [Related]
16. Allelotype analysis of mouse skin tumors using polymorphic microsatellites: sequential genetic alterations on chromosomes 6, 7, and 11.
Kemp CJ; Fee F; Balmain A
Cancer Res; 1993 Dec; 53(24):6022-7. PubMed ID: 7903201
[TBL] [Abstract][Full Text] [Related]
17. UV-induced DNA damage and mutations in Hupki (human p53 knock-in) mice recapitulate p53 hotspot alterations in sun-exposed human skin.
Luo JL; Tong WM; Yoon JH; Hergenhahn M; Koomagi R; Yang Q; Galendo D; Pfeifer GP; Wang ZQ; Hollstein M
Cancer Res; 2001 Nov; 61(22):8158-63. PubMed ID: 11719445
[TBL] [Abstract][Full Text] [Related]
18. A malignant melanoma tumor suppressor on human chromosome 11.
Robertson G; Coleman A; Lugo TG
Cancer Res; 1996 Oct; 56(19):4487-92. PubMed ID: 8813145
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
20. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
